Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.72 USD | -1.33% | -4.86% | -45.75% |
May. 13 | European Equities Traded in the US as American Depositary Receipts Kick Off Week Higher | MT |
May. 06 | European Equities Traded in the US as American Depositary Receipts Rise in Monday Trading | MT |
Financials (USD)
Sales 2024 * | 6.27M | Sales 2025 * | 18.26M | Capitalization | 20.4M |
---|---|---|---|---|---|
Net income 2024 * | -11M | Net income 2025 * | -3M | EV / Sales 2024 * | 3.26 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 1.12 x |
P/E ratio 2024 * |
-2.71
x | P/E ratio 2025 * |
-1.91
x | Employees | 49 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 83.4% |
Latest transcript on Evaxion Biotech A/S
1 day | +1.34% | ||
1 week | -3.58% | ||
Current month | -9.59% | ||
1 month | -8.05% | ||
3 months | -5.75% | ||
6 months | -45.27% | ||
Current year | -45.02% |
Managers | Title | Age | Since |
---|---|---|---|
Andreas Mattsson
FOU | Founder | - | 08-08-10 |
Niels Møller
FOU | Founder | 46 | 08-08-10 |
Chief Executive Officer | 52 | 23-08-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 54 | 17-12-31 | |
Lars Holtug
BRD | Director/Board Member | 66 | 21-05-24 |
Marianne Søgaard
CHM | Chairman | 56 | 17-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-14 | 3.72 | -1.33% | 11 891 |
24-05-13 | 3.77 | +1.34% | 10,468 |
24-05-10 | 3.72 | -1.33% | 6,204 |
24-05-09 | 3.77 | -2.58% | 2,946 |
24-05-08 | 3.87 | -1.02% | 9,856 |
Delayed Quote Nasdaq, May 13, 2024 at 04:30 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-45.02% | 20.4M | |
+26.37% | 48.16B | |
-1.01% | 41.73B | |
+46.00% | 41.03B | |
-5.31% | 28.77B | |
+9.34% | 25.59B | |
-21.69% | 18.96B | |
+6.23% | 12.92B | |
+26.99% | 12.03B | |
-3.38% | 11.77B |
- Stock Market
- Equities
- EVAX Stock